Butterfly Network (BFLY) Cash from Financing Activities (2020 - 2026)
Butterfly Network recorded quarterly Cash from Financing Activities of $2.3 million in Q1 2026, up 236.47% quarter-over-quarter from -$1.7 million in Q4 2025, and down 97.06% year-over-year from $78.5 million in Q1 2025.
Butterfly Network's Cash from Financing Activities history runs 7 years deep, the most recent figure standing at $2.3 million for Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 97.06% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $1.6 million (down 97.92% YoY), while the FY2025 annual figure was $77.8 million, up 5301.47% from the prior year.
- Cash from Financing Activities came in at $2.3 million for Q1 2026 at Butterfly Network, up from -$1.7 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $78.5 million in Q1 2025 to a low of -$1.7 million in Q4 2025.
- A 5-year average of $7.4 million and a median of $159000.0 in 2022 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities tumbled 99.9% in 2022 and retreated 13.18% in 2025, its largest moves.
- Butterfly Network's Cash from Financing Activities stood at $137000.0 in 2022, then sank by 32.85% to $92000.0 in 2023, then sank by 1725.0% to -$1.5 million in 2024, then fell by 13.18% to -$1.7 million in 2025, then jumped by 236.47% to $2.3 million in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $2.3 million, -$1.7 million, and $987000.0 for Q1 2026, Q4 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Butterfly Network | 1.17 Bn | 1.04 Bn | 18.29 Mn | 2.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.31 Mn |
| Mar 31, 2026 | 2.31 Mn |
| Dec 31, 2025 | -1.69 Mn |
| Dec 31, 2025 | -1.69 Mn |
| Jun 30, 2025 | 987,000.00 |
| Jun 30, 2025 | 987,000.00 |
| Mar 31, 2025 | 78.47 Mn |
| Mar 31, 2025 | 78.47 Mn |
| Dec 31, 2024 | -1.50 Mn |
| Dec 31, 2024 | -1.50 Mn |
| Sep 30, 2023 | 92,000.00 |
| Sep 30, 2023 | 92,000.00 |
| Jun 30, 2023 | 136,000.00 |
| Jun 30, 2023 | 136,000.00 |
| Dec 31, 2022 | 137,000.00 |
| Dec 31, 2022 | 137,000.00 |
| Sep 30, 2022 | 2.04 Mn |
| Sep 30, 2022 | 2.04 Mn |
| Jun 30, 2022 | 159,000.00 |
| Jun 30, 2022 | 159,000.00 |
| Mar 31, 2022 | 550,000.00 |
| Mar 31, 2022 | 550,000.00 |
| Dec 31, 2021 | 2.39 Mn |
| Dec 31, 2021 | 2.39 Mn |
| Sep 30, 2021 | 7.63 Mn |
| Sep 30, 2021 | 7.63 Mn |
| Jun 30, 2021 | 5.40 Mn |
| Jun 30, 2021 | 5.40 Mn |
| Mar 31, 2021 | 550.27 Mn |
| Mar 31, 2021 | 550.27 Mn |
| Dec 31, 2020 | 28.92 Mn |
| Dec 31, 2020 | 28.92 Mn |
| Sep 30, 2020 | 618,000.00 |
| Sep 30, 2020 | 618,000.00 |
| Jun 30, 2020 | 24.59 Mn |
| Jun 30, 2020 | 24.59 Mn |
| Mar 31, 2020 | 154,000.00 |
| Mar 31, 2020 | 154,000.00 |